Prime Medicine, Inc. — All Filings
279 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001628280-25-029770 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001628280-25-029773 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001628280-25-029771 | Jun 5, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001628280-25-029646 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001894562-25-000030 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001894562-25-000026 | May 22, 2025 | May 21, 2025 |
| 4 | FORM 4 | 0001894562-25-000028 | May 22, 2025 | May 21, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-122158 | May 19, 2025 | — |
| 4 | FORM 4 | 0001894562-25-000023 | May 19, 2025 | — |
| 4 | FORM 4 | 0001894562-25-000024 | May 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-122156 | May 19, 2025 | May 16, 2025 |
| 4 | FORM 4 | 0001894562-25-000019 | May 12, 2025 | May 8, 2025 |
| 4 | FORM 4 | 0001894562-25-000020 | May 12, 2025 | May 8, 2025 |
| 4 | FORM 4 | 0001894562-25-000018 | May 12, 2025 | May 8, 2025 |
| 8-K | 8-K | 0001628280-25-023482 | May 8, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-023486 | May 8, 2025 | Mar 31, 2025 |
| ARS | ARS | 0001628280-25-018708 | Apr 22, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001628280-25-018704 | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001628280-25-018706 | Apr 22, 2025 | — |
| 8-K | 8-K | 0001193125-25-056122 | Mar 18, 2025 | — |
| 4 | FORM 4 | 0001894562-25-000014 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | FORM 4 | 0001894562-25-000006 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | FORM 4 | 0001894562-25-000002 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | FORM 4 | 0001894562-25-000008 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | FORM 4 | 0001894562-25-000010 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | FORM 4 | 0001894562-25-000012 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | FORM 4 | 0001894562-25-000004 | Mar 3, 2025 | Feb 27, 2025 |
| S-8 | S-8 | 0001628280-25-008885 | Feb 28, 2025 | — |
| 8-K | 8-K | 0001628280-25-008873 | Feb 28, 2025 | — |
| 10-K | 10-K | 0001628280-25-008884 | Feb 28, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001493152-25-006876 | Feb 14, 2025 | — |
| 8-K | 8-K | 0001628280-25-001244 | Jan 13, 2025 | — |
| EFFECT | — | 9999999995-24-003900 | Dec 20, 2024 | — |
| CORRESP | — | 0001193125-24-281271 | Dec 18, 2024 | — |
| UPLOAD | — | 0000000000-24-013902 | Dec 17, 2024 | — |
| S-3 | S-3 | 0001628280-24-051126 | Dec 13, 2024 | — |
| 4 | FORM 4 | 0001894562-24-000049 | Dec 9, 2024 | Dec 5, 2024 |
| 4 | FORM 4 | 0001894562-24-000048 | Dec 9, 2024 | Dec 5, 2024 |
| 4 | FORM 4 | 0001894562-24-000047 | Dec 9, 2024 | Dec 5, 2024 |
| SC 13D/A | ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D/A(#1) | 0001072613-24-000898 | Nov 22, 2024 | — |
| SC 13G/A | — | 0000315066-24-002848 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001628280-24-047119 | Nov 12, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-047130 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001628280-24-043500 | Oct 24, 2024 | — |
| 4 | FORM 4 | 0001894562-24-000043 | Oct 10, 2024 | Oct 8, 2024 |
| 8-K | 8-K | 0001628280-24-041541 | Sep 30, 2024 | Sep 28, 2024 |
| 8-K | 8-K | 0001628280-24-035886 | Aug 8, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-035893 | Aug 8, 2024 | Jun 30, 2024 |
| 4 | FORM 4 | 0001894562-24-000040 | Jun 14, 2024 | Jun 12, 2024 |
| 4 | FORM 4 | 0001894562-24-000041 | Jun 14, 2024 | Jun 12, 2024 |